CDKN2B and central nervous system cancer: The rs4977756 is mapped 59 kb telomeric to CDKN2B within a 122-kb region of LD at 9p21.3, which encompasses the CDKN2A-CDKN2B tumor suppressor genes and was shown to be associated with the risk of glioma [37, 38].